An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancer

This publication has 17 references indexed in Scilit:

• Early serum CA125 response and outcome in epithelial ovarian cancer
  European Journal of Cancer and Clinical Oncology, 1990
• The prognostic significance of the half‐life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma
  BJOG: An International Journal of Obstetrics and Gynaecology, 1989
• Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group.
  Journal of Clinical Oncology, 1989
• The treatment of advanced ovarian carcinoma (I): Clinical variables associated with prognosis
  Gynecologic Oncology, 1988
• Evaluation of serum CA 125 levels in the monitoring of ovarian cancer
  American Journal of Obstetrics and Gynecology, 1987
• The clinical significance of pre-operative serum CA 125 in ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1987
• CA125 as a serum marker for poor prognosis in ovarian malignancies
  Gynecologic Oncology, 1987
• CA 125 FOR THE MONITORING OF OVARIAN-CARCINOMA DURING PRIMARY THERAPY
  1987
• Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
  British Journal of Cancer, 1984
• Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary
  American Journal of Obstetrics and Gynecology, 1984